Given the rise in newborn screening for ALD since 2019, and the untapped potential of existing genetic research, the Halls ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Some truly iconic Resident Evil characters don't need to transform into grotesque creatures to prove they are intensely scary ...

As a people, we must begin to frown upon material acquisitiveness and the lavish life-styles of people without visible or ...

A recent paper published in Science magazine by researcher Blanca Barquera, Ph.D., professor of biological sciences at ...

A teen with a rare eye disease wants to travel the world while she still has her eyesight. The girl has been told she's going ...

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

Revenue camps related to mutation were organized simultaneously in 10 zones of Ranchi district on Sunday. Out of a total of 1134 cases, 534 were approved in the mutation revenue camp while 460 cases ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

This paper addresses the important question of quantifying epistasis patterns, which affect the predictability of evolution, by reanalyzing a recently published combinatorial deep mutational scan ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...